Back to Search
KIMBERLY DIVITO, PHARMD
PHARMD
Pharmacist
NPI: 1528357837Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
03328462(OH)
Research & Publications (10)
Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis.
PMID 19451188·Carcinogenesis·2009
7-preclinical
UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.
PMID 19054058·Exp Dermatol·2009
8-other
Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
PMID 17804730·Cancer Res·2007
8-other
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
PMID 16778114·Clin Cancer Res·2006
8-other
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
PMID 16033835·Clin Cancer Res·2005
8-other
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
PMID 15574790·Cancer Res·2004
8-other
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
PMID 15574789·Cancer Res·2004
8-other
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.
PMID 15179190·Melanoma Res·2004
8-other
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model.
PMID 14767486·Lab Invest·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21800 LIBBY RD
MAPLE HEIGHTS, OH 44137 - Phone
- (216) 662-7470
Quick Facts
- NPI
- 1528357837
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile